The National Institutes of Health (NIH) has established a pandemic preparedness research network, called ReVAMPP, to focus on developing vaccines and monoclonal antibodies for high-priority pathogens. The network will receive approximately $100 million per year to fund research on prototype pathogens from virus families known to infect humans and potential pandemic threats. The goal is to fill knowledge gaps and develop medical countermeasures before a critical need arises. The network will focus on viruses from families such as Bunyavirales, Flaviviridae, Paramyxoviridae, Picornaviridae, and Togaviridae. Centralized coordination and data sharing will be provided by the Research Triangle Institute in Durham, North Carolina.
Source link
New research network focuses on high-priority viruses
